A randomised comparative clinical study on the effect of hutabugadi choorna and murvadi choorna in pandu.
Overview
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Dr Pallavi S
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Srama/Fatigue
Overview
Brief Summary
This is a randomized comparative clinical study to evaluate the effect of hutabugadi choorna and moorvadi choorna in management of symptoms of pandu for 30 days this study comprises of two groups of 30 patients seected as inclusion and exclusion criteria study will be conducted in ALN Rao memorial ayurvedic hospitals in koppa koppa taluk chikmaglur 577126 karnataka India.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Subjects with the lakshanas of panduta, dourbalya, hataanila, srama, bhrama, and hrutspandana, of pandu.
- •2.Hb percentage more than 8 gmpercent & less than 13gmpercent in male, less than 12gm percent in females.
- •3.Subjects above the age of 18 years and below 60 years irrespective of caste, gender, religion and socio-economic status.
- •4.Subjects must be capable of giving informed consent, willingness and ability to comply with scheduled visits, treatment plans and laboratory tests and other study procedure.
Exclusion Criteria
- •1.Patients with uncontrolled systemic diseases like Diabetes Mellitus and Hypertension.
- •2.Endocrine disorders like hypothyroidism, Cushing syndrome, etc.
- •3.Patient having tuberculosis, known case of HIV, leprosy, any type of Cancer.
- •4.Patients with infectious diseases such as chickenpox, dengue etc.
- •5.Haemoglobinopathies such as Sickle cell anaemia, Leukaemia and Thalassaemia.
- •Pregnant and lactating women 7.Patients with active bleeding disorders like Haemorrhoids, menorrhagia, gastro intestinal bleeding.
- •8.Anaemia in a case of defective absorption due to gastrectomy, sprue syndrome etc.
Outcomes
Primary Outcomes
Srama/Fatigue
Time Frame: 30 days
Bhrama/Giddiness
Time Frame: 30 days
Hrutspandana/Palpitations
Time Frame: 30 days
Panduta of Tvaka, Nakha, Netravartma, Jihva, Hastapadatala/Paleness of skin,eye,tongue,foot and palm.
Time Frame: 30 days
Dourbalya/Generalised weakness
Time Frame: 30 days
Hataanila/Reduction of digestive fire
Time Frame: 30 days
Secondary Outcomes
- Not applicable(Not applicable)
Investigators
Dr Pallavi S
ALN Rao Memorial Ayurvedic Medical College Koppa Chikkamagaluru Karnataka India